Question from Deputy Ken O'Flynn - PQ 15880-26
Deputy O'Flynn asked about the reimbursement to tirzepatide and semaglutide. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked about the reimbursement to tirzepatide and semaglutide. Read the HSE response.
Deputy Ward asked about the number of additional staff that needed in each community hospital in Donegal. Read the HSE response.
Deputy O'Flynn asked whether any clinical risk assessment, patient safety review, or governance audit has been undertaken on gender healthcare services.
Deputy O'Flynn asked about the health technology assessments conducted in respect of tirzepatide. Read the HSE response.
Deputy O'Flynn asked about the approval of a dataset or outcome monitoring system for gender identity services for children and young people.
Deputy O'Flynn asked about the gross and net weekly income thresholds applicable to applicants aged 70 years and over for a medical card. Read the HSE response.
Deputy Toole asked about the contingency plan for the provision of general practitioner services in Ratoath and Dunboyne in Meath. Read the HSE response.
Deputy O'Flynn asked whether all publicly funded chronic pain services operate in accordance with a nationally approved clinical model. Read the HSE response.
Deputy O'Flynn asked about the gender-related healthcare services for children and adolescents. Read the HSE response.
Deputy O'Flynn asked about the reimbursement of tirzepatide for weight management. Read the HSE response.